Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Q2 2016: Continued healthy growth and a transforming acquisition

SECOND QUARTER OF 2016 · NET SALES amounted to MSEK 73.3 (59.0). · OPERATING PROFIT totalled MSEK 20.7 (15.7). Operating profit includes acquisition costs in the amount of 7.5 MSEK · PROFIT AFTER TAX amounted to MSEK 17.1 (10.8). · PROFIT AFTER TAX PER SHARE was SEK 1.87 (1.19). · CHANGES IN CASH AND CASH EQUIVALENTS amounted to MSEK 16.4 (neg: 5.1). Probi paid dividends of MSEK 9.1 (7.7). ACCUMULATED 2016 · NET SALES amounted to MSEK 160.3 (127.9). · OPERATING PROFIT totalled MSEK 56.0 (43.0). Operating profit includes acquisition costs in the amount of 7.5 MSEK

Inwido signs agreement to acquire CWG Choices in the UK

This information is information that Inwido AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation.The information was submitted for publication, through the agency of the contact persons set below, at Friday, 15 July 2016 at 8:45 a.m. Inwido, Europe’s largest supplier of windows and doors, has signed an agreement to acquire the British window and door company CWG Choices. CWG Choices is a leading manufacturer of double and triple glazed PVCu windows and doors covering the Midlands and South of England. Inwido acquires 100 percent of the shares in CWG Choices for

Beijer Ref Q2 2016

A strong quarterNet sales increased by 12.3 per cent compared with the corresponding quarter last year and amounted to SEK 2,417M (2,153). The increase is mainly due to a continued positive development in the Southern Europe market region relating to air-conditioning products. Operating profit amounted to SEK 186M (158). The improved profit is mainly the result of increased sales. In June, the UK Competition & Markets Authority (CMA) approved the acquisition of HRP Ltd which was consolidated in the Group’s operation from June. Net profit for the period increased to SEK 121M (107).

Sobi's Board of directors exercises its authorisation for repurchase of shares to secure the company’s commitments under the incentive programme

The annual general meeting of Swedish Orphan Biovitrum AB (publ)  (Sobi™) on 24 May 2016 resolved – for the purpose of ensuring that the company can fulfill its commitments under the long-term incentive programme resolved by the annual general meeting – on a directed share issue of no more than 188,142 redeemable and convertible class C shares. The general meeting also resolved to authorise the board of directors to resolve on the repurchase of all issued class C shares by an offer directed to all holders of class C shares. Repurchase under this authorisation may be

Interim report January-June 2016: Good growth and broadened product portfolio

Second quarter: · Sales amounted to SEK 208 (184) million, corresponding to an increase of 13 percent in SEK. Net sales growth was 15 percent in local currency. · Operating income before depreciation and amortisation (EBITDA) amounted to SEK 74 (62) million, corresponding to a margin of 35 (34) percent. · Net income amounted to SEK 48 (39) million, which gave earnings per share of SEK 2.21 (1.77). · Acquisition of all the shares in OCTAX and MTG, world-leaders in the field of laser technology for IVF. · Vitrolife introduces EmbryoScope+ and broadens the time-lapse product

Cantargia obtains a granted patent from USPTO concerning IL1RAP in solid tumors

The United States Patent and Trademark Office (”USPTO”) has granted Cantargia AB’s (“Cantargia”) patent application concerning IL1RAP as a target molecule for antibody therapy of several solid tumor types. The granted patent follows the Notice of Allowance that was issued and communicated in June 2016.The granted patent with number US 9,403,906 B1 planned to be published August 2, 2016, concerns Cantargias method to utilize IL1RAP as a target molecule for the treatment of several types of solid tumors. The patent provides protection until 2032 and covers treatment of several common forms of

INTERIM REPORT 1 APRIL 2016 - 30 JUNE 2016

“Strong organic growth”· Net sales in the fourth quarter rose by 74 percent to SEK 465.0 million (267.1), of which organic growth totalled 10 percent. · EBITA rose by 41 percent to SEK 46.4 million (32.9) and EBITA-margin amounted to 10.0 percent (12.3). · Profit after tax amounted to SEK 26.4 million (22.1). · During the quarter the Company carried out a rights issue of SEK 300 million to existing shareholders; the issue was oversubscribed by about 70 percent. · Two acquisition have been carried out during the quarter, with a combined annual sale of about SEK 50 million.

Autoliv has refinanced its existing Revolving Credit Facility

((Stockholm, July 15, 2016) – – – Autoliv (NYSE: ALV och SSE: ALIVsdb), Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb), the worldwide leader in automotive safety systems has refinanced its existing $1.1 billion multi-currency revolving credit facility agreement with a group of 14 banks. The facility has a five-year maturity, with extension options for up to two more years. The facility agreement is for general corporate purposes and replaces our existing $1.1 billion syndicated facility, which matures in April 2018.Autoliv is pleased to announce that the refinancing of its existing core $1.1

XVIVO Perfusion Interim report January – June 2016

ACQUISITION OF VIVOLINE STRENGTHENS XVIVO’S PRODUCT AND R&D PORTFOLIOSECOND QUARTER 2016 (APR – JUN) • Net sales in the quarter amounted to SEK 34.5 (29.1) million, corresponding to an increase of 18 percent. Net sales of non-Durable goods* in the quarter amounted to SEK 29.8 (27.4) million, corresponding to an increase of 9 percent in SEK and 11 percent in local currency.• Operating income before depreciation and amortization (EBITDA) excluding one-time expenses increased by 51 percent and amounted to SEK 6.9 (4.6) million, corresponding to an EBITDA margin of 20 percent. One-time

Notification of major holdings of own shares

East Capital Explorer AB’s (publ) total holding of its own shares per 14 July 2016 amounts to 1,428,930 shares. The Company’s holding of own shares thereby corresponds to 5.1 percent of the total number of outstanding shares and votes in the Company. The total number of outstanding shares, including repurchased, amounts to 28,161,563.   Contact information Mia Jurke, CEO, East Capital Explorer, +46 8 505 885 32 Lena Krauss, CFO and Head of Investor Relations, East Capital Explorer, +46 73 988 44 66 About East Capital Explorer  East Capital Explorer AB (publ) is a Swedish

NRC GROUP ASA - APPOINTED TO A MAJOR CONTRACT IN NORWAY - NOK 108 MILLION

Obrascón Huarte Lain S.A (OHL), a Spanish international concessions and construction group, has appointed NRC Rail Norge AS (NRC), a company wholly owned by NRC Group ASA, to a contract of track works relating to the EPC Ski contract. The EPC Ski contract is part of the Follo Line Project, currently the largest transport project in Norway. The contract is valued at approximately NOK 108 million. The work will commence in February 2017, and the main part of the project will be executed in the period 2017 to 2018. The project is the largest track contract ever awarded to NRC, and

Blackstone enters into agreements to acquire a major stake in D. Carnegie & Co.

London/Stockholm, July 15, 2016 Blackstone Real Estate Partners Europe IV and Blackstone Real Estate Partners VIII (jointly “Blackstone”), through its entity Vega Holdco Sarl, have at 08.00 AM this morning entered into agreements with three of D. Carnegie & Co.’s largest shareholders Kvalitena AB (“Kvalitena”), Svensk Bolig Holding AB (”SBH”), and Frasdale Int. BV (“Frasdale”) to acquire part of or all of their shareholdings, subject to certain conditions, at a price of SEK 100.00 per share. Blackstone views the transaction as an opportunity to invest in a leading, high-quality,

AAK increases its presence in the U.S. further as leading California based company is acquired

AAK has acquired the leading West Coast based vegetable oils company California Oils Corporation from Mitsubishi Corporation of Japan. California Oils Corporation, also known as CalOils, had last year revenues of approximately SEK 1,350 million and a volume of approximately 110,000 MT, with 65 employees. “A strong presence on the U.S. West Coast has been priority for AAK since several years. The West Coast encompasses 20 percent of the U.S. population and this expansion has been identified as an important component of AAK’s long-term growth strategy. The acquisition of CalOils will

Clas Ohlson publishes Annual Report for 2015/16

Today Clas Ohlson publishes the Annual Report and Sustainability Report for 2015/16 at about.clasohlson.com.The printed version of the Annual Report is being distributed to shareholders who have notified their wish to have it sent, but can also be ordered via e-mail ir@clasohlson.se  or telephone +46 247 444 00. The Annual Report and Sustainability Report are available in both Swedish and English version. This is information that Clas Ohlson AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was

Interim report January - June 2016

In the second quarter, Byggmax increased net sales by + 34%April 1 - June 30 • Net sales amounted to SEK 1,738.7 M (1,294.6), up 34.3 percent. Pro forma net sales totaled SEK 1,584.0 M for the second quarter of 2015, corresponding to a pro forma net sales increase of 9.8 percent. • Net sales for comparable stores increased 6.1 percent (10.3). • The gross margin was 29.9 percent (29.3). • EBITDA amounted to SEK 193.8 M (151.4). Pro forma EBITDA was SEK 192.8 M for the second quarter of 2015. • The EBITDA margin was 11.1 percent (11.7). The pro forma EBITDA margin was 12.2

REPORT ON THE SECOND QUARTER 2016

Q2: Strong organic growth and margin expansion in all regions· Net sales for the second quarter totaled SEK 3,461 million (3,202), an increase of 8%, of which 9% was organic growth. · Operating profit (EBIT) before items affecting comparability amounted to SEK 584 million (484), representing a margin of 16.9% (15.1%). · Operating profit (EBIT) amounted to SEK 573 million (463). · Cash flow for the period totaled SEK 309 million (-550). Operating cash flow totaled SEK 511 million (342). · Profit for the second quarter was SEK 453 million (198). · Earnings per share:

Interim report January - June 2016

Kai Wärn, President and CEO:“The positive development continued in the second quarter, despite lower demand for lawn and garden products in North America, which was affected by unfavorable weather. Group operating income increased with SEK 54m to SEK 1,729m (1,675), including a currency head-wind of close to SEK -170m for the quarter, and the corresponding margin improved to 15.0% (13.7) The higher result was driven by a positive product mix as well as a successful execution of efficiency improvements. Sales in the Husqvarna Division increased 3% adjusted for currency. Sales developed

Sales development in June 2016

The H&M group’s sales including VAT increased by 8 percent in local currencies in June 2016 compared to the same month the previous year. The total number of stores amounted to 4,095 on 30 June 2016 compared to 3,642 on 30 June 2015. Percentage sales development for the month of July will be published on 15 August 2016 at 08.00 (CET). Karl-Johan Persson, CEO Contact: Nils Vinge, Head of IR, +46 8 796 5250 +------------------------------------------------------------------------------+|The information in this press release is that which H & M Hennes & Mauritz AB ||(publ)

President and CEO David Nuutinen comments on the results for the second quarter of 2016

Good sales growth and improved operating profit.Cloetta’s sales were up in the quarter, both organically and through acquisitions. Operating profit (EBIT) for the quarter improved and amounted to SEK 142m (130). Operating profit, adjusted for items affecting comparability, also strengthened to SEK 150m (133). Profit after tax increased to SEK 77m (66). Both operating profit margin and operating profit margin adjusted, improved to 10.4 per cent (10.2) and 11.0 per cent (10.4) respectively. The improvement in profit and margins was mainly driven by higher efficiency in supply chain but also

Sobi publishes its report for the second quarter 2016

Swedish Orphan Biovitrum AB (publ)  (Sobi™) today announced its results for the second quarter 2016. Revenue for the quarter totalled SEK 1,469 M (764), an increase of 92 per cent compared to previous year. All parts of the business contributed to the result with Haemophilia, Inflammation and Partner Products delivering strong performance. Business Summary Q2 2016 · Alprolix® approved in the EU with first sales reported in Germany in early June · Elocta® approved in Switzerland · European patent granted on new formulation of Kineret® · Signed licensing

Interim report January-June 2016: Strong financial performance during the period

· Best quarterly- and half year result in the company’s history  · Increased profitability in our Nordic clinics  · Organic growth continues to be good ·  Situation analysis in United Arab Emirates completed    Second quarter 2016 · Sales revenues increased to SEK 262.0 million (212.1) and organic growth amounted to 22 percent (6) ·  EBITDA amounted to SEK 31.8 million (17.8) ·  EBITDA margin amounted to 12.1 percent (8.4) ·  Result after tax (EAT) amounted to SEK 20.1 million (8.6) ·  Result per share amounted to SEK 0.26 (0.10)   First half year 2016

Interim report January - June 2016

STABLE DEMAND AND CONTINUED STRONG SALES· According to segment reporting, revenue increased to SEK 7,727m (7,233) and operating profit increased to SEK 893m (771). The operating margin increased to 11.6 percent (10.7) · Restated according to IFRIC 15, revenue increased to SEK 7,336m (6,785) and the operating profit increased to SEK 824m (722). This restatement is attributable to JM International and had a negative effect on earnings of SEK –69m (–49) · Profit before tax increased to SEK 801m (691). Profit after tax increased to SEK 617m (527) · Return on equity for the past twelve

Interim report, Q2, April – June 2016

· Net sales for the quarter increased by 6.4 per cent to SEK 1,362m (1,280), including a negative impact from foreign exchange rates of –0.5 per cent. Organic growth was 2.0 per cent. · Operating profit increased to SEK 142m (130). · Cash flow from operating activities amounted to SEK 114m (163). · Net debt/EBITDA ratio was 2.82x (3.30). This information is information that Cloetta AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out

INTERIM REPORT JANUARY – JUNE 2016

THE PERIOD AND THE SECOND QUARTER · Net sales amounted to MSEK 165.6 (2.3), whereof the second quarter MSEK 83.3 (1.8) · Earnings before depreciation were MSEK 12.6 (-36.1), whereof the second quarter MSEK 3.3 (-21.2). The second quarter includes one-off costs for cost reductions in acquired companies amounting to MSEK 6. · Earnings per share amounted to SEK 0.00 (-0.91), whereof the second quarter SEK -0.04 (-0.53) · Cash and cash equivalents at period end amounted to MSEK 157.6 (19.1) · A share issue of MSEK 250 was carried out and, due to the high interest garnered, a

There are no items matching the current filter
There are no more items matching the current filter
Back to top